HSV-1 and HSV-2 are the two herpes simplex viruses behind oral and genital herpes. The biggest practical difference is recurrence. Genital HSV-2 comes back and sheds virus far more often than genital HSV-1, which usually flares once and then quiets down. HSV-1 traditionally causes cold sores but increasingly causes genital infections through oral sex CDC.
about 12%
but well controlled
| Item | Value |
|---|---|
| Adults 14–49 with HSV-2 | ~1 in 8 — about 12% |
| Unaware they have it | ~87% |
| Daily antivirals cut spread | ~50% |
| Cure | none — but well controlled |
What HSV-1 and HSV-2 actually mean
Both are members of the same viral family, and both establish a lifelong, latent infection in the nerve roots after the first exposure. There's no cure. The virus parks itself in a nerve cluster and reactivates from time to time, traveling back to the skin to cause an outbreak. Antiviral drugs can suppress those flares, but they don't clear the latent virus or change how the infection behaves once you stop taking them.
The old textbook split was simple: HSV-1 caused cold sores on the mouth, HSV-2 caused genital herpes. That line has blurred, and either virus can infect either site. Where the virus sets up shop matters more than the label. The location plus the type together drive how often you'll have outbreaks and how easily you might pass it on.
Most people carry one of these viruses without knowing it. Symptoms are absent or so mild they get mistaken for something else, and the majority of HSV-2 infections are never diagnosed. If you're trying to tell a flare apart from skin irritation, it's worth reading up on herpes vs razor burn before you assume the worst.
The key differences that change your prognosis
This isn't about which virus is "worse" in some abstract sense. It comes down to recurrence and shedding at the genital site. Genital HSV-2 recurs and sheds virus much more frequently than genital HSV-1 CDC STI guidelines. That one fact shapes treatment decisions, disclosure conversations, and how you think about transmission.
In real numbers: genital HSV-1 tends to recur about once in the first year and then taper off, while genital HSV-2 averages roughly four recurrences a year HSV-1 college cohort. So someone with genital HSV-1 often has a rough first outbreak and then very little trouble, while someone with genital HSV-2 is more likely to have ongoing, repeated flares.
Who's getting what has also shifted. In a US young-adult cohort, the share of new genital herpes caused by HSV-1 climbed from 31% to 78%, driven largely by oral sex, where oral HSV-1 transfers to a partner's genitals. That trend has an upside, because genital HSV-1 generally means fewer outbreaks and less shedding over a lifetime.
A first outbreak from either virus can be uncomfortable: blisters that break into painful sores taking a week or more to heal, sometimes with flu-like symptoms like fever, body aches, and swollen glands. Repeat outbreaks are shorter and milder, and many people get a warning prodrome (tingling, itching, or burning at the spot a day before sores appear).
One difference doesn't favor either type: you can transmit herpes with no symptoms at all. People with HSV-2 shed virus on about 10% of days even when they never have an outbreak, and most of that shedding leaves no visible sore JAMA. Most genital herpes spreads this way, from someone who doesn't know they're infected.
HSV-1 vs HSV-2 side by side
| Feature | HSV-1 | HSV-2 |
|---|---|---|
| Classic site | Mouth/lips (cold sores) | Genitals, rectum |
| Can infect genitals? | Yes — increasingly common via oral sex | Yes — the traditional cause |
| Genital recurrences | Few (about once in year one, then tapers) | More frequent (about four per year) |
| Asymptomatic shedding (genital) | Less frequent | More frequent (~10% of days) |
| Cure available? | No — lifelong, antivirals control only | No — lifelong, antivirals control only |
| Link to HIV acquisition | Not the same established link | Raises HIV acquisition risk two- to three-fold |
| First-outbreak symptoms | Similar — painful sores ± flu-like illness | Similar — painful sores ± flu-like illness |
Which one applies to you, and how to find out
You can't tell the two apart by how a sore looks; only a type-specific test can. If you have an active sore, swab the lesion and test it by NAAT or culture. These swab-based tests work best and will tell you the exact type. Go in while the sore is fresh, because the test gets less reliable as the sore heals. A clinic visit during an outbreak gets you the most reliable diagnosis. Read more about herpes testing to know what to ask for.
If you have no sore, a type-specific blood (serologic) test can sometimes help, but timing matters: it can take up to 16 weeks or more for current tests to detect a new infection CDC testing. If you're checking after a specific encounter, look at when to test after exposure so you don't test too early and get a falsely reassuring result.
Routine herpes blood screening is not recommended if you have no symptoms. The CDC advises against it in most situations, and the USPSTF gives it a Grade D recommendation against routine serologic screening in asymptomatic teens and adults, including during pregnancy USPSTF 2023. Blood tests produce a lot of false positives, and a wrong result causes real anxiety and relationship strain. Asking for a herpes blood panel "just to be safe" with no symptoms often creates more problems than it solves.
The practical next step
If you have a sore right now, get it swabbed at a clinic before it heals. If you've had a possible exposure but no symptoms, time your testing correctly rather than rushing in. Herpes isn't part of a standard panel without symptoms, so be specific about what you want. When you're ready to screen for the rest, you can get tested for the infections that are recommended for routine screening.
Whatever the type, treatment is the same three FDA-approved antivirals — acyclovir, valacyclovir, and famciclovir — which control symptoms without curing. You can take them episodically (at the start of an outbreak to shorten it) or daily as suppressive therapy. Suppressive therapy cuts recurrences by 70%–80% in frequent recurrers and lowers the chance of passing HSV-2 to a partner. In a trial of serodiscordant couples, daily valacyclovir reduced transmission by about 48% Corey et al.. These are cheap generics, so cost is rarely the barrier. The full breakdown lives on our genital herpes treatment page.
Condoms reduce HSV-2 transmission but don't eliminate it, since they can't cover every patch of affected skin. The reliable risk-reducers are disclosure to partners and, if you choose, daily suppressive therapy. The biggest avoidable mistake is assuming "no sore means no risk," because asymptomatic shedding spreads the virus quietly under that assumption.
This is a manageable skin condition. Most people have few outbreaks over time, those flares tend to shrink, and daily antivirals can make them rare while lowering the odds of passing it on. The type you have shifts your odds, and genital HSV-1 is usually the gentler course, but neither one defines you.
When to see a clinician
- You have new or recurring blisters or painful sores on the genitals, rectum, or mouth — get swabbed while the sore is fresh.
- Your first outbreak comes with fever, body aches, or swollen glands, or the sores are severe — you may benefit from prompt antiviral treatment.
- You're pregnant or planning pregnancy: herpes during pregnancy can cause miscarriage or preterm delivery, and neonatal herpes is a potentially deadly infection in the baby. Suppressive acyclovir late in pregnancy can reduce the need for cesarean, and women with recurrent lesions at the start of labor should have a cesarean.
- You have frequent outbreaks and want to discuss daily suppressive therapy — for your own comfort and to protect a partner.
- You have HSV-2 and a partner who is HIV-negative, since HSV-2 raises HIV acquisition risk two- to three-fold.